Workers' Comp
COVID-19 Drug Therapy Treatments: Potential Impact on Workers' Comp
May 7, 2020
MIN READ
More stories
WorkCompWire
Article
WorkCompWire: Michael Valasek: Ensuring a Quality IME Result: Three Players in the Process
A certain amount of contention has come to surround the independent medical examination (IME) process.
Mitchell
News Release
Pennsylvania SB 936 Advances—Press Conference on Opioids Follows
Pennsylvania legislature is considering a bill to establish a drug formulary in the state.
Workers' Comp
Article
CMS Commercial Repayment Center (CRC) Contractor Transition
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the Medicare Set-Aside services Genex provides.
Workers' Comp
Article
CMS Commercial Repayment Center (CRC) Contractor Transition
Keep current with new legislation and its potential effect on your organization.
Mitchell
Article
Survey Results: The Future of Technology in Workers’ Compensation
The workers’ compensation industry in general has been conservative about adopting new technologies. However, as we start 2018, it is clear that technology is going to play an even bigger role in our market than ever. In fact, with rising health care costs, changing regulations and the need to create operational efficiencies, the industry cannot afford to not adopt these new technologies.
Workers' Comp
White Paper
A Prescription for Fighting Opioid Use Disorder
The rampant opioid misuse battering the nation represents one of the most virulent threats to employee welfare in the more than 100-year history of workers’ compensation protections. Equipping key players with an understanding of what to look for and how to respond will lead to better chances of deterring the abuse of opioid analgesics that has proven so costly to workers’ wellbeing.